Home / Health / New Malaria Cure 'Plasmochin' Outperforms Quinine
New Malaria Cure 'Plasmochin' Outperforms Quinine
24 Sep
Summary
- A synthetic preparation named Plasmochin offers a new malaria cure.
- Plasmochin showed greater effectiveness than quinine in tests.
- Experiments were first conducted on lunatics infected with malaria.
A significant advancement in malaria treatment was announced at the Scientists' and Doctors' Congress in Duesseldorf. A novel synthetic preparation, dubbed "Plasmochin," was unveiled, with researchers claiming superior effectiveness over the established drug, quinine.
Early experimental trials of Plasmochin were conducted by Professor Shell. These initial studies involved infecting individuals with malaria germs. Subsequently, the drug underwent more extensive testing by Professor Muchlens at the Hamburg Tropical Institute. Over a hundred malaria patients from diverse global regions participated in these later trials.
The results from these comprehensive tests indicated a high success rate, with "Plasmochin" reportedly achieving permanent cures in a substantial number of patients. The breakthrough represents a potentially vital new weapon in the global fight against malaria, offering hope for more effective and lasting treatment.
